Ten age-matched subjects with comparable CD4+ lymphopenia were recruited: 5 cancer patients receiving ASCT 9 months before observation (ASCT) and 5 HIV+ antiretroviral naïve subjects (HIV). This evidence concerns the gene CD4 and lymphopenia.